Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 18, 2022
Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational studyJulien Dang, Lauriane Segaux, Anissa Moktefi, et al.
ESC Heart Failure|February 7, 2022
Prevalence and determinants of iron deficiency in cardiac amyloidosisAntoine Jobbé-Duval, Mélanie Bézard, Stéphane Moutereau, et al.
Respiratory Medicine|July 23, 2017
Heterogeneity of lung disease associated with NK2 homeobox 1 mutationsElodie Nattes, Stephanie Lejeune, Ania Carsin, et al.
European Journal of Heart Failure|October 23, 2020
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosisMélanie Bézard, Mounira Kharoubi, Arnault Galat, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Biochemical methods to assess CFTR expression and membrane localizationCarlos M Farinha, Deborah Penque, Mónica Roxo-Rosa, et al.
Orphanet Journal of Rare Diseases|December 5, 2019
Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosisRaphael Borie, Caroline Kannengiesser, Laurent Gouya, et al.
Human Mutation|June 13, 2017
CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variantsMireille Claustres, Corinne Thèze, Marie des Georges, et al.
ESC Heart Failure|October 29, 2021
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosisMounira Kharoubi, Mélanie Bézard, Arnault Galat, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosisMounira Kharoubi, Mélanie Bézard, Amaury Broussier, et al.
Transplantation Direct|June 24, 2022
Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac AmyloidosisSoulef Guendouz, Philippe Grimbert, Costin Radu, et al.
Pageof 8